US HB8529 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on October 6 2020 - 25% progression, died in committee
Action: 2020-10-06 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on October 6 2020 - 25% progression, died in committee
Action: 2020-10-06 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Prohibits additional rebates for certain drugs under the Medicaid Drug Rebate Program. Specifically, the bill prohibits additional rebates with respect to noninnovator multiple-source drugs (i.e., generics) for which the average manufacturer price is less than $1.
Title
Protecting Access to Affordable Medicines Act of 2020
Sponsors
Rep. G. Butterfield [D-NC] | Rep. Billy Long [R-MO] | Rep. Tony Cardenas [D-CA] | Rep. Tom O'Halleran [D-AZ] |
Rep. Darren Soto [D-FL] | Rep. David McKinley [R-WV] | Rep. Dan Bishop [R-NC] |
History
Date | Chamber | Action |
---|---|---|
2020-10-06 | House | Referred to the House Committee on Energy and Commerce. |
2020-10-06 | House | Introduced in House |
Subjects
Health
Home and outpatient care
Inflation and prices
Medicaid
Prescription drugs
State and local government operations
Home and outpatient care
Inflation and prices
Medicaid
Prescription drugs
State and local government operations
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/house-bill/8529/all-info |
Text | https://www.congress.gov/116/bills/hr8529/BILLS-116hr8529ih.pdf |